πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 82 of 200 Β· A–Z by INN

  1. gadoterate meglumine

    GADOTERATE MEGLUMINE

    INTRAVENOUS FDA: approved

  2. gadoteridol

    PROHANCE

    INJECTION FDA: approved

  3. gadoversetamide

    OPTIMARK

    INJECTION FDA: approved Β· EMA: withdrawn

    V08CA06
  4. gadoxetate disodium

    EOVIST

    INTRAVENOUS FDA: approved

  5. galantamine

    REMINYL Alphapharm Pty Ltd

    TGA: approved

  6. galantamine hydrobromide

    GALANTAMINE HYDROBROMIDE

    ORAL FDA: approved

  7. galcanezumab

    EMGALITY

    EMA: approved Β· TGA: approved Β· PMDA: approved

    N02
  8. galcanezumab-gnlm

    EMGALITY

    INJECTION FDA: approved

  9. gallamine triethiodide

    FLAXEDIL

    INJECTION FDA: approved

  10. gallium (68ga) chloride

    GALLIAPHARM

    EMA: approved

    V09X
  11. gallium citrate ga-67

    NEOSCAN

    INJECTION FDA: approved

  12. gallium dotatate ga-68

    NETSPOT

    INTRAVENOUS FDA: approved

  13. gallium ga-68 edotreotide

    GALLIUM GA 68 EDOTREOTIDE

    INTRAVENOUS FDA: approved

  14. gallium ga-68 gozetotide

    ILLUCCIX Telix Innovations

    INTRAVENOUS FDA: approved

  15. gallium nitrate

    GANITE

    INJECTION FDA: approved

  16. galsulfase

    NAGLAZYME BioMarin Pharmaceutical Australia Pty Ltd

    INJECTION FDA: approved Β· EMA: approved

    A16AB
  17. ganaxolone

    ZTALMY

    ORAL FDA: approved Β· EMA: approved

    N03AX
  18. ganciclovir

    VITRASERT IMPLANT

    OPHTHALMIC FDA: approved Β· EMA: withdrawn

    J05AB06
  19. ganciclovir product

    CYMEVENE Lacuna Pharma Pty Ltd

    TGA: approved

  20. ganciclovir sodium

    GANCICLOVIR SODIUM Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  21. ganirelix

    ARX GANIRELIX Alphapharm Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    H01CC01
  22. ganirelix acetate

    FYREMADEL Amphastar France Pharmaceuticals

    INJECTION FDA: approved

  23. garadacimab

    ANDEMBRY

    EMA: approved Β· PMDA: approved

    B06AC07
  24. garadacimab-gxii

    ANDEMBRY

    SUBCUTANEOUS FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources